Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Type 2 Diabetes Mellitus.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00328627
What this trial is testing

Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.

Who this might be right for
Type 2 Diabetes Mellitus
Takeda 1,554
Large-scale testing (Phase 3)Study completedNCT01095666
What this trial is testing

A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone

Who this might be right for
Type 2 Diabetes
AstraZeneca 1,484
Testing effectiveness (Phase 2)Study completedNCT03555994
What this trial is testing

Investigate the Effect of MEDI0382 on Hepatic Glycogen Metabolism in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.

Who this might be right for
Type 2 Diabetes Mellitus
MedImmune LLC 51
Not applicableWithdrawnNCT04228003
What this trial is testing

Pendulum D2D Glucose Control for Adults With Type 2 Diabetes

Who this might be right for
Type2 DiabetesGastrointestinal Symptoms
University of Southern California
Large-scale testing (Phase 3)Study completedNCT02099110
What this trial is testing

Ertugliflozin and Sitagliptin Co-administration Factorial Study (VERTIS FACTORAL, MK-8835-005)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 1,233
Post-approval studies (Phase 4)Study completedNCT00770835
What this trial is testing

Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.

Who this might be right for
Diabetes Mellitus
Takeda 39
Large-scale testing (Phase 3)Study completedNCT01885208
What this trial is testing

Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 813
Testing effectiveness (Phase 2)Study completedNCT03514420
What this trial is testing

Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Partial Lipodystrophy (FPL)

Who this might be right for
Familial Partial Lipodystrophy
Akcea Therapeutics 4
Early research (Phase 1)Study completedNCT01650324
What this trial is testing

A Single-dose Phase 1 Study of DBPR108 in Healthy Male Subjects

Who this might be right for
Diabetes Mellitus, Type 2
National Health Research Institutes, Taiwan 32
Early research (Phase 1)Study completedNCT00501462
What this trial is testing

A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function

Who this might be right for
Type 2 Diabetes MellitusDiabetes Mellitus, Type 2Renal Insufficiency
GlaxoSmithKline 29
Post-approval studies (Phase 4)Looking for participantsNCT06478186
What this trial is testing

Knee Osteoarthritis Treatment With Zilretta vs. Kenalog in the Context of Type II Diabetes

Who this might be right for
Osteoarthritis, KneeDiabetes Mellitus, Type 2
University of Kansas Medical Center 120
Very early researchUnknownNCT04203927
What this trial is testing

Effects of Empagliflozin on Cardiac Microvasculature and Insulin Sensitivity in Subjects With Type 2 Diabetes

Who this might be right for
Type2 DiabetesInsulin Sensitivity
University of Virginia 50
Not applicableUnknownNCT02443922
What this trial is testing

Dynamic Responsiveness of Insulin Secretory Parameters To Sitagliptin and Glimeperide Administration in Type 2 DM

Who this might be right for
Type 2 Diabetes
Foundation for the National Institutes of Health 100
Large-scale testing (Phase 3)Study completedNCT00286429
What this trial is testing

Efficacy and Safety Study of Alogliptin and Insulin in the Treatment of Type 2 Diabetes.

Who this might be right for
Diabetes Mellitus
Takeda 390
Not applicableLooking for participantsNCT06904690
What this trial is testing

JACARDI: A eHealth and Health Literacy Educational Training to Support Older Patients With Type II Diabetes

Who this might be right for
Type 2 Diabetes
Istituto Nazionale di Ricovero e Cura per Anziani 200
Testing effectiveness (Phase 2)Study completedNCT06688123
What this trial is testing

Efficacy and Safety of SHR-3167 and Insulin Glargine in Type 2 Diabetes Subjects

Who this might be right for
Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 275
Early research (Phase 1)Study completedNCT00972322
What this trial is testing

Pharmacokinetics and Pharmacodynamics of MK-8245 in Participants With Type 2 Diabetes (MK-8245-012)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 56
Not applicableStudy completedNCT00788853
What this trial is testing

A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Indonesia

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 1,832
Not applicableUnknownNCT03792646
What this trial is testing

Protein Supplementation: Body Composition, Muscle Strength and Postural Balance

Who this might be right for
Diabetes Mellitus, Type 2Protein SupplementationBody Composition+2 more
University of Sao Paulo General Hospital 40
Large-scale testing (Phase 3)UnknownNCT05054842
What this trial is testing

Clinical Study of Retagliptin Phosphate Combined With Metformin in the Treatment of Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 174
Next Page